USD10
ALKS Shares
About AlkermesAlkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
USD10
ALKS Shares
About AlkermesAlkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$4.90B
OPEN PRICE
$29.90
LOW (1Y)
$25.17
HIGH (1Y)
$36.32
LOW (24H)
$29.20
HIGH (24H)
$30.05
VOLUME (24H)
$2.07M
39.37%
Price history
Time | Price | Change |
|---|---|---|
Today | $29.90 | |
1 Day | $29.39 | 0.00% |
1 Week | $28.59 | |
1 Month | $30.50 | |
1 Year | $33.02 |